IMIPRAMINE-FENTANYL ANTINOCICEPTION IN A RABBIT TOOTH-PULP MODEL

被引:6
作者
BERGMAN, SA
WYNN, RL
ALVAREZ, L
ASHER, K
THUT, PD
机构
[1] Department of Pharmacology, Dental School, University of Maryland at Baltimore, Baltimore, MD 21201
关键词
D O I
10.1016/0024-3205(91)90191-D
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Antinociception of imipramine (I) and its effect in combination with fentanyl (F) was evaluated in rabbits using electrically-induced lick chew responses via tooth pulp stimulation as the model of nociception. Acute i.v. injections of I elicited a graded dose response comparable to i.v. morphine (M) with I ED 50 = 4.35 mg/kg (2.31-8.14, 95% CL) and M ED 50 = 1.81 mg/kg (1.11-3.90), with no differences in the slopes between the two curves. The lethal dose of I was 10 mg/kg. An i.v. dose of I twice the ED 50 elicited an antinociceptive effect of more than 50% maximum possible effect (MPE) for 90 minutes with peak effect of 82% MPE occurring at 15 minutes. These effects of I were not reversed by a morphine-reversal dose of naloxone (0.1 mg/kg i.v.) but were reversed with a ten fold dose of naloxone. F ED 50 values (mcg/kg) were lowered from 11.35 to 2.70, 0.74 and 0.33 with increasing pretreatment doses of I (1.0, 2.1 and 3.2 mg/kg). These magnitudes of potency increases of F were 4.2, 15.3 and 34.4 fold respectively. A single i.v. ED 50 dose of I extended the time to 50% MPE of an ED 90 dose of F from 26 minutes to 77 minutes; of a 2 X ED 50 dose of F from 17 minutes to 28 minutes. Data points for three different combinations of I and F fell significantly within the synergistic field of an ED 50 isobologram and a polynomial equation described the curve best fitting the data points. F alone (i.v. ED 50 dose) increased the PaCO2 values to 74% above controls and three different combinations with I showed no increases in PaCO2 values above controls. I alone did not significantly cause any change in PaCO2 values from controls.
引用
收藏
页码:1279 / 1288
页数:10
相关论文
共 36 条
[1]   ANTI-DEPRESSANTS AND OPIATES INTERACTIONS - PHARMACOLOGICAL AND BIOCHEMICAL EVIDENCES [J].
BARALDI, M ;
POGGIOLI, R ;
SANTI, M ;
VERGONI, AV ;
BERTOLINI, A .
PHARMACOLOGICAL RESEARCH COMMUNICATIONS, 1983, 15 (09) :843-857
[2]   EVIDENCE THAT AN EXCITATORY CONNECTION BETWEEN THE PERIAQUEDUCTAL GRAY AND NUCLEUS RAPHE MAGNUS MEDIATES STIMULATION PRODUCED ANALGESIA [J].
BEHBEHANI, MM ;
FIELDS, HL .
BRAIN RESEARCH, 1979, 170 (01) :85-93
[3]   INTERACTION OF TRICYCLIC ANTI-DEPRESSANTS WITH OPIATE RECEPTORS [J].
BIEGON, A ;
SAMUEL, D .
BIOCHEMICAL PHARMACOLOGY, 1980, 29 (03) :460-461
[4]   AMITRIPTYLINE POTENTIATES MORPHINE ANALGESIA BY A DIRECT ACTION ON THE CENTRAL NERVOUS-SYSTEM [J].
BOTNEY, M ;
FIELDS, HL .
ANNALS OF NEUROLOGY, 1983, 13 (02) :160-164
[5]   ORIGINS OF SEROTONERGIC PROJECTIONS TO THE SPINAL-CORD IN RAT - AN IMMUNOCYTOCHEMICAL-RETROGRADE TRANSPORT STUDY [J].
BOWKER, RM ;
WESTLUND, KN ;
COULTER, JD .
BRAIN RESEARCH, 1981, 226 (1-2) :187-199
[6]  
BROWN B, 1986, PAIN, V25, P245
[7]   AMITRIPTYLINE IN MIGRAINE PROPHYLAXIS [J].
COUCH, JR ;
HASSANEIN, RS .
ARCHIVES OF NEUROLOGY, 1979, 36 (11) :695-699
[8]  
DEFELIPE MD, 1986, EUR J PHARMACOL, V125, P193
[9]   PSYCHOGENIC FACIAL-PAIN - PRESENTATION AND TREATMENT [J].
FEINMANN, C ;
HARRIS, M ;
CAWLEY, R .
BMJ-BRITISH MEDICAL JOURNAL, 1984, 288 (6415) :436-438
[10]  
France RD, 1988, CHRONIC PAIN, p322 374